Edwards Lifesciences Corporation (NYSE:EW) Q3 2020 Earnings Conference Call October 21, 2020 5:00 PM ET Company Participants Mark Wilterding - President, Investor Relations Mike Mussallem - Chairman and Chief Executive Officer Scott Ullem - Chief Financial Officer Conference Call Participants David Lewis - Morgan Stanley Bob Hopkins - Bank of America Joanne Wuensch - Citi Raj Denhoy - Jefferies Robbie Marcus - JPMorgan Matt Miksic - Credit Suisse Danielle Antalffy - SVB Leerink Adam Maeder - Piper Sandler M ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) (State or other jur ...

Edwards Lifesciences Corp. (NYSE:EW) Q2 2020 Earnings Conference Call July 23, 2020 5:00 PM ET Company Participants Mark Wilterding – Vice President-Investor Relations Mike Mussallem – Chairman and Chief Executive Officer Scott Ullem – Chief Financial Officer Conference Call Participants Josh Jennings – Cowen and Company David Lewis – Morgan Stanley Matt Miksic – Credit Suisse Bob Hopkins – Bank of America Robbie Marcus – JPMorgan Larry Biegelsen – Wells Fargo Matt Taylor – UBS Raj Denhoy – Jefferies Chris ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-431661 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission File Number 1-15525 | --- | --- | --- | |-----------------------------------------------------------------------|------------------ ...

Edwards Lifesciences Corporation (NYSE:EW) Q4 2019 Earnings Conference Call January 30, 2020 5:00 PM ET Company Participants Mark Wilterding - VP, IR Mike Mussallem - Chairman & CEO Scott Ullem - CFO Conference Call Participants Bob Hopkins - Bank of America Merrill Lynch David Lewis - Morgan Stanley Raj Denhoy - Jefferies Larry Biegelsen - Wells Fargo Kristen Stewart - Barclays Jason Mills - Canaccord Genuity Robbie Marcus - JPMorgan Matt Taylor - UBS Vijay Kumar - Evercore ISI Suraj Kalia - Oppenheimer & ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) (State or othe ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-4316614 ...

Edwards Lifesciences Corporation (NYSE:EW) Q2 2019 Earnings Conference Call July 23, 2019 5:00 PM ET Company Participants Mark Wilterding - IR Mike Mussallem - Chairman and CEO Scott Ullem - CFO Conference Call Participants Bob Hopkins - Bank of America David Lewis - Morgan Stanley Vijay Kumar - Evercore ISI Larry Biegelsen - Wells Fargo Joanne Wuensch - BMO Capital Markets Robbie Marcus - JPMorgan Cecilia Furlong - Canaccord Genuity Matt Taylor - UBS Matt Miksic - Credit Suisse Josh Jennings - Cowen & Comp ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ýQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2019 or oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-15525 EDWARDS LIFESCIENCES CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-4316614 ...